Hospital Practices and Research

Abstract We wish to highlight a growing concern in urological practice about the increasing rates of sepsis and systemic infections following transrectal ultrasound-guided prostate biopsy (TRUS-PB). Despite being the traditional gold standard for prostate cancer diagnosis, the transrectal method is progressively associated with severe infectious complications, primarily driven by the global rise in antimicrobial resistance.